article summary：
The procurement strategy for medical device production lines, particularly for complex products like insulin pens, fundamentally shapes a pharmaceutical company's manufacturing capabilities. The industry is currently defined by two distinct deployment models: the traditional OEM approach and the Project-Delivery model.
The Traditional OEM Model
The OEM (Original Equipment Manufacturer) model focuses primarily on delivering specialized equipment. In this approach, the pharmaceutical manufacturer must independently coordinate the pen platform supplier, manage complex interfaces between different machines, and internally generate all validation and RA/QA documentation from scratch. While this allows for highly customized modular setups, it often results in extended deployment timelines and increased integration risks.
The Project-Delivery Model
The project-delivery model represents a comprehensive approach that encompasses equipment manufacturing, platform coordination, and structured documentation support.
DROFEN MACHINERY's Approach
DROFEN MACHINERY represents the project-delivery model. We organize the project into clear, deliverable modules:
•Core Equipment: Final Assembly Line & Pre-Assembly Equipment
•Platform Coordination: Sample pens, engineering samples, and interface development
•Validation Support: Standardized FAT/SAT, IQ/OQ templates, and parameter matrices
•Regulatory Technical Support: Technical dossiers and audit preparation materials for RA/QA teams
By delivering a standardized technical support package alongside the equipment, DROFEN helps customers reduce detours, clear implementation paths, and move faster toward project execution without taking on the legal role of the regulatory holder.
Related Technical Resources